Julie Bernhardt | |
---|---|
Personal details | |
Nationality | Australian |
Occupation | Physiotherapist |
Julie Bernhardt is an Australian physiotherapist and clinician scientist, known for her work in the field of stroke recovery. She has been a principal research fellow and an NHMRC senior research fellow and clinical head of the Stroke Division at the Florey Institute of Neuroscience and Mental Health, University of Melbourne.
As of 2018 [update] Bernhardt is the director of the NHMRC Centre of Research Excellence (CRE) in Stroke Rehabilitation and Brain Repair, a collaboration between the Florey Institute of Neuroscience and Mental Health, the Hunter Medical Research Institute and other institutions. [1] She founded and chaired the international Stroke Recovery and Rehabilitation Roundtable (SRRR), a partnership involving leading stroke experts which aims to advance stroke rehabilitation research. [2] She led the second SRRR in 2018, on developing international clinical trials to improve stroke treatment. [3]
In 1985, Bernhardt completed a Bachelor of Applied Science in Physiotherapy at the Lincoln Institute of Health Sciences in Melbourne. [4]
From 1990 to 1995 she undertook a Masters of Applied Science at La Trobe University, Melbourne, where she also received her PhD in 1999. [4] The focus of her PhD research was on the hemiplegic upper limb, and she developed new methods of testing the accuracy of observational kinematic assessment of upper limb dysfunction. [5] [6] [7]
Bernhardt began work as a physiotherapy research coordinator at Melbourne Health in 1989, [8] then after completing her PhD, she was a senior physiotherapist at the Austin and Royal Melbourne Hospitals from 1999–2008. [9]
She became a professor in neuroscience at La Trobe in 2006. Bernhardt is[ when? ] head of Stroke Division at the Florey Institute of Neuroscience and Mental Health at the University of Melbourne. [4]
In 2004, Bernhardt joined the Florey Institute to become Principal Investigator of the AVERT Early Intervention Research Group. AVERT was the largest acute stroke rehabilitation trial in the world. Over 2000 stroke patients were recruited from 56 acute stroke units in Australia, New Zealand, the United Kingdom, Malaysia, and Singapore from 2006–2014. [10] Within the AVERT group, Bernhardt led a team of over 1000 clinicians and researchers. The trial aimed to identify if receiving very early mobilisation (VEM) within 24 hours of stroke is beneficial for stroke recovery, and if so, how much and what frequency is best. [11] The studies in AVERT focused on understanding how these early exercise-based interventions after stroke may alter bone, muscle and brain. [9] The results of AVERT were presented at the European Stroke Organisation Conference in Glasgow in April 2015. While AVERT was completed in 2016, Bernhardt continued to lead the extension of the trial, AVERT-DOSE (Determining Optimal early rehabilitation after Stroke). [12] This trial tests eight different mobility training regimens to see what dose of mobility training is best early after stroke. AVERT-DOSE is recruiting over 2500 patients in six countries: Australia, New Zealand, the United Kingdom, Malaysia, Singapore, and India. [12]
From 2006 to 2014, Bernhardt was a non-executive director for the National Stroke Foundation. She has been on the Steering Committee of the Australian Stroke Research Network since 2011 and from 2013–16, she was co-chair for Australasian Stroke Trials Network. [13]
In 2015, Bernhardt became a director of the NHMRC Centre of Research Excellence in Stroke Rehabilitation, [1] which aims to accelerate discovery and translation in the field of stroke rehabilitation [14] She was chair of the research committee for the World Federation of Neurorehabilitation from 2016 to 2020. Bernhardt has been on the board of the World Stroke Organisation since July 2014 and Chair of the research committee of WSO since April 2017. [13]
She also founded and leads[ when? ] the Stroke Recovery and Rehabilitation Roundtable, which brings together researchers, clinicians, funders and consumers to identify key stroke research priority areas. [2]
In 2013, Bernhardt founded the Women in Science Parkville Precinct (WiSPP) Collective Impact initiative to address the gender inequity that she had witnessed in medical research. [15] This initiative aims to improve the systems that limit the advancement of women and diversity of leadership across five of Melbourne's medical research institutes. Bernhardt was invited to talk at the 2016 World Economic Forum in Tianjin, China about gender equity [16] and is also an author on a paper about gender equity in Stroke Society of Australasia. [17]
Bernhardt has published 345 scholarly works, most in the field of stroke rehabilitation. [26]
As of 2014 [update] Bernhardt lived in Melbourne with her husband and teenage son. [27]
Mirror therapy (MT) or mirror visual feedback (MVF) is a therapy for pain or disability that affects one side of the patient more than the other side. It was invented by Vilayanur S. Ramachandran to treat post-amputation patients who had phantom limb pain (PLP). Ramachandran created a visual illusion of two intact limbs by putting the patient's affected limb into a "mirror box," with a mirror down the center.
The Royal Melbourne Hospital (RMH), located in Parkville, Victoria, an inner suburb of Melbourne, is one of Australia's leading public hospitals. It is a major teaching hospital for tertiary health care with a reputation in clinical research. The hospital is managed as part of Melbourne Health which comprises the Royal Melbourne Hospital, North West Dialysis Service and North Western Mental Health. The Royal Melbourne Hospital appointed Professor Shelley Dolan as the new Chief Executive following an international search. She succeeded Professor Christine Kilpatrick AO, who stepped down on 30 June 2023.
The Austin Hospital is a public teaching hospital in Melbourne's north-eastern suburb of Heidelberg, and is administered by Austin Health, along with the Heidelberg Repatriation Hospital and the Royal Talbot Rehabilitation Centre.
The Florey Institute of Neuroscience and Mental Health, more commonly known as The Florey, is an Australian medical research institute that undertakes research into treatments for brain and mind disorders. The institute's areas of interest include Parkinson's disease, stroke, motor neurone disease, addiction, epilepsy, multiple sclerosis, Autism, Huntington's disease, depression, schizophrenia, brain function in health and disease, heart failure, and dementia.
Faculty of Medicine, Dentistry and Health Sciences is the largest faculty of University of Melbourne, with the most post-graduate students, and also hosts the most school departments and centres of all University of Melbourne Faculties, consisting of 52 faculty sub-organisations. In 2021, Melbourne Medical School was ranked 25th in the world and second in Australia in the 2021 QS Subject Rankings.
Louise McCullough is an American neurologsit who is the Prof. Roy M. & Phyllis Gough Huffington Distinguished Chair of Neurology and is actively engaged in stroke research at the University of Texas Health Science Center in Houston, Texas. She provides neurological care at Memorial Hermann Hospital, which has a state-of-the-art stroke center and is co-director of the Mischer Neuroscience Institute.
The Mental Health Research Institute (MHRI) is a former Australian medical research institute that was focused upon improving the diagnosis, treatment and prevention of major mental disorders. The MHRI was active between 1956 and 2012, when it was merged with the Florey Neuroscience Institutes to form the Florey Institute of Neuroscience and Mental Health. Based in Melbourne, Victoria, the research efforts of the MHRI were focused on understanding schizophrenia, bipolar and major mood disorders, and Alzheimer's disease.
Ruth Frances Bishop was an Australian virologist, who was a leading member of the team that discovered the human rotavirus.
John F. Kennedy University Medical Center (JFKMC), an affiliate of Hackensack Meridian Health (HMH), is a 499-bed full-service, acute care hospital, and the home of the JFK Johnson Rehabilitative Institute. It is affiliated with Hackensack Meridian School of Medicine and Robert Wood Johnson Medical School, and is located in Edison, New Jersey. In 2021 it announced an affiliation with the St. Joseph's Wayne Medical Center, also in New Jersey.
Neuroscience Research Australia is an independent, not for profit medical research institute based in Sydney, Australia. The institute is made up of over 400 researchers specialising in research to improve the lives of people living with brain and nervous system disorders. The institute’s research spans neurodegeneration, including dementia and Parkinson’s disease; mental health and mental illness including bipolar disorder and schizophrenia; and translational neuroscience including falls prevention, pain and injury prevention.
Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.
Aleksandra Filipovska is an Australian biochemist and molecular biologist. She is a professor, Deputy Director of the ARC Centre of Excellence in Synthetic Biology and NHMRC Investigator at the University of Western Australia, heading a research group at the Telethon Kids Institute. Specializing in biochemistry and molecular biology, she has made contributions to the understanding of human mitochondrial genetics in health and disease.
Elizabeth Scarr is an Australian scientist. Her research investigates the chemical changes in the brain associated schizophrenia and bipolar disorder.
Jennie Louise Ponsford is an Australian neuroscience researcher at Monash University, Victoria who works on Traumatic Brain Injury (TBI). Ponsford is a clinical neuropsychologist, whose work is focused on developing a deeper understanding of the negative consequences of TBI, particularly those related to fatigue, sleep disturbance, attentional, memory and executive problems, psychiatric and behavioural disturbances and sexuality, and the development of rehabilitation interventions to improve long term recovery and quality of life in individuals with TBI.
Professor Leeanne Carey is a world leading Australian neuroscientist in occupational therapy and stroke rehabilitation and recovery research. She is the founding leader of the Neurorehabilitation and Recovery research group in the Stroke division at the Florey Institute of Neuroscience and Mental Health in Melbourne, Australia, and currently holds a Future Fellowship awarded by the Australian Research Council (ARC).
Mary Pauline Galea is an Australian physiotherapist and neuroscientist at University of Melbourne. She resides in Melbourne, Australia. Galea is a professorial fellow at the University of Melbourne's Department of Medicine at the Royal Melbourne Hospital and a Senior Principal Fellow in the Florey Institute of Neurosciences and Mental Health. She was foundation professor of clinical physiotherapy and director of the Rehabilitation Sciences Research Centre at the University of Melbourne and Austin Health. She is internationally recognised for her work in spinal cord injury and rehabilitative interventions.
Matire Louise Ngarongoa Harwood is a New Zealand clinical researcher and trainee general practitioner. She is an associate professor at the University of Auckland. Harwood was the 2017 New Zealand L'Oréal UNESCO For Women in Science Fellow. Her expertise is in Māori health, focussed on reducing health inequity by improving indigenous health and well-being.
Anne Kelso is an Australian biomedical researcher specialising in immunology and influenza. She is the Chief Executive Officer of the Australian Government's National Health and Medical Research Council (NHMRC).
Rachelle Buchbinder is an Australian rheumatologist and clinical epidemiologist. Her clinical practice is in conjunction with research involving multidisciplinary projects relating to arthritis and musculoskeletal conditions. She promotes improvement of communication with patients and health literacy in the community.
Julie Bines, is a clinician and researcher working in Melbourne, Australia. Alongside being a professor and deputy head of the Department of Paediatrics at the University of Melbourne, she is also a paediatric gastroenterologist at the Royal Children's Hospital Melbourne and is the leader of the Enteric Diseases group at the Murdoch Children's Research Institute. Bines is the joint head of the WHO Collaborative Centre for Child Health and founding member of Women in Global Health Australia.